Flavopiridol (alvocidib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Flavopiridol (alvocidib), covering 2014-12-23 to 2014-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms [Phase 1]